A Validated Stability Indicating RP-HPLC Method for the Determination of Tenofovir in Bulk and Tablet Dosage Forms
 
More details
Hide details
1
School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
2
Shri Gopichand College of Pharmacy, Baghpat, Uttar Pradesh, India
CORRESPONDING AUTHOR
Pradeep Kumar   

School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
Publication date: 2017-10-21
 
Eurasian J Anal Chem 2012;7(2):104–114
 
KEYWORDS
ABSTRACT
A rapid, precise, accurate, specific and simple RP-HPLC method was developed for the estimation of Tenofovir in its tablet form. A High performance liquid chromatograph 10AT SHIMADZU- SPD10A, using Phenomenex - Luna RP-18(2),250X4.6mm, 5 μm column, with mobile phase composition of Acetonitrile: water [78:22 %(v/v)] was used. The flow rate of 1.0 mL min-1 and effluent was detected at 260 nm. The retention time of Tenofovir was 5.541 minutes. Linearity was observed over concentration range of 500-4000 ng mL-1. The Limit of detection was found to be 74.80 ng mL-1 while quantification limit was 226.68 ng mL-1. The accuracy of the proposed method was determined by recovery studies and found to be 98.465 to 100.003%. Commercial tablet formulation was successfully analyzed using the developed method and the proposed method is applicable to stability studies and routine analysis of Tenofovir in bulk and pharmaceutical formulations. The proposed method was validated for various ICH parameters like linearity, limit of detection, limits of quantification, accuracy, precision, range and specificity.
 
REFERENCES (12)
2.
2 Kathy S (2008) Gilead Sciences Inc. said the Food and Drug Administration granted approval to market Viread for the treatment of chronic hepatitis B, http://online.wsj.com/article/....
 
3.
3 Sudha T, Saminathan J, Hemalatha P V, Ravikumar V R (2010) Estimation of Tenofovir and Emtricitabine in bulk and in tablet Dosage form by Spectrophotometric method. Int J Biopharma 1: 26-30.
 
4.
4 Ghorpade SA, Sali MS, Kategaonkar AH, Patel DM, Choudhari VP, Kuchekar BS. (2010) Simultaneous determination of emtricitabine and tenofovir by area under curve and dual wavelength spectrophotometric method. J Chil Chem Soc 54:331-33.
 
5.
5 Mirna B, Marie G, Jérôme (2007) Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring. Journal of Chromatography B. 854, 1:192-197.
 
6.
6 Todd J, Kavita M, Judit F, Theodore H (2010) Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. European J Pharma Sci 39(4): 203-212.
 
7.
7 Nirogi R, Bhyrapuneni G, Kandikere V, Mudigonda K, Komarneni P, Aleti R, Mukkanti K (2009) Simultaneous quantification of a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry. Biomed Chromatogr 23(4):371-81.
 
8.
8 Kandagal P B, Manjunatha D H, Seetharamappa J S, Kalanur S (2008) RP-HPLC Method for the Determination of Tenofovir in Pharmaceutical Formulations and Spiked Human Plasma. Analytical Letters 41, 4:561 – 570.
 
9.
9 FDA, Guidance for Industry: Impurities in Drug Product, Draft Guidance, Center for Drug Evaluation and Research (CDER), 1998.
 
10.
10 International Conference on Harmonization (ICH), Guidance for Industry, Q1A (R2): Stability Testing of New Drug Substances and Products, IFPMA, Geneva, 2003.
 
11.
11 Grimm W, Cartensen J T and Rhodes C T (Eds) Drug Stability, Principles and Practices, Marcel Dekker, New York, 2000.
 
12.
12 International Conference on Harmonization (ICH), Validation of Analytical Procedures: Text and Methodology Q2 (R1), November 2005.
 
eISSN:1306-3057